Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 22, 2021 at 02:20 pm IST
Share
Jiangsu Apon Medical Technology Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 324.22 million compared to CNY 244.59 million a year ago. Revenue was CNY 324.22 million compared to CNY 244.59 million a year ago. Net income was CNY 48.44 million compared to CNY 58.26 million a year ago. Basic earnings per share from continuing operations was CNY 0.3843 compared to CNY 0.4622 a year ago. Diluted earnings per share from continuing operations was CNY 0.3843 compared to CNY 0.4622 a year ago.
Jiangsu Apon Medical Technology Co., Ltd. is a China-based company which is mainly engaged in research, development, production and sales of medical device products for pain management and nasal care. The Company's main products include medical devices such as micro-computer injection pumps, disposable drug injection pumps, wireless analgesia management systems, pulse oximeters and sensors for pain management, and nasal care applications such as nasal care sprayers. Among them, medical devices used in the field of pain management are mainly used for infusion and monitoring of drug treatment in postoperative, childbirth, cancer and other clinical treatments to alleviate pain in patients; medical devices used in nasal care are mainly used to relieve nasal dryness, nasal congestion and nose discomfort such as bleeding in patients. The Company operates primarily in domestic and overseas markets.